ALBANY, New York, July 13, 2012 /PRNewswire/ --

New Report Added in ResearchMoz Reports Database Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Media

GBI Research, the leading business intelligence provider, has released its latest research, Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Media, which provides insights into the up-and-coming trends of DTC advertising in the US and of awareness campaigns in Europe. The report provides an in-depth analysis of the types of marketing channels available to pharmaceutical marketers. In particular it focuses on how pharmaceutical marketers can make the most of digital media channels, including online advertising and social media.

To Browse Full TOC, Tables & Figures visit:  http://www.researchmoz.us/direct-to-consumer-dtc-advertising-in-pharmaceuticals-shift-from-traditional-mass-media-platforms-towards-personalization-via-online-and-social-media-report.html 

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.

In 2006, over $5 billion was spent on DTC advertising, most of it on the most expensive medium, television. Since then, DTC expenditure has decreased. This is due to a number of reasons, notably the emergence of new media for advertising. Since advertising moved onto the internet, there have been many developments which have revolutionized the way that products are promoted. Pharmaceutical companies were slow to move their advertising online but are now beginning to use it to their advantage. The internet has proven itself to be one of the most cost-effective forms of advertising; full campaigns can be run for the price of one television advertisement.

Social media is another risky yet rewarding method of promotion that pharmaceutical companies are beginning to explore. Through social media, consumers expect to be able to have a public conversation with the representatives of a brand; consumers will always expect their questions to be answered and will not hesitate to discuss adverse effects and any other problems that they consider to be the fault of a brand. However, through social media, pharmaceutical companies have an opportunity to improve their brand image through their responses to these enquires. Another huge advantage of social media is the sharing between friends and peer groups that it enables. A recommendation from a friend is trusted by 90% of people and 70% trust consumer opinions posted online (Google, 2011), so campaigns that are spread between friends by word of mouth can be more effective than traditional methods of widely broadcast DTC.

Scope

- Data and analysis of traditional media channels and newer channels such as online and mobile platforms.

- Suggestions of how the ROI (return on investment) of a social media campaign can be measured.

- How to target a campaign to appropriate audiences by altering the media mix.

- Examples of successful and violative campaigns.

- Examples of pioneering use of online media channels.

- How DTC advertising techniques can be transferred to unbranded campaigns in countries where DTC is not permitted.

Reasons to buy

- Understand how DTC advertising has changed over the last decade.

- Develop the use of new media types such as social media and mobile.

- Create a more tailored advertising campaign designed to reach a targeted audience.

- Develop key strategic initiatives by understanding the way that patients use different media.

- Accelerate the delivery of marketing messages through word-of-mouth communication.

Report Category: Pharmaceutical

Browse All  GBI Research Latest Reports & Industry Analysis

Latest Reports by GBI Research

Active Pharmaceutical Ingredients (API) Market in Europe

Direct to Consumer (DTC) Advertising in Pharmaceuticals

Multi-Targeted Therapies

Biobetters in Key Markets

Protein and Peptide-based Therapeutics

Biobanks - 2012 Year Book

Biosimilars in Developed Countries

Pharmaceutical Pricing and Reimbursement in Oncology

Novel Therapies in Oncology

Pharmaceutical Supply Chain in Europe

Major Power Markets in Eastern Europe to 2020

About Us

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Contact

M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-997-4948
Email: sales@researchmoz.com

http://www.researchmoz.us/ http://marketresearchinsights.blogspot.de/ 

SOURCE ResearchMoz